Dnaprint Genomics Stock Analysis

DNAPrint Stock Analysis Notes

The company had not issued any dividends in recent years. DNAPrint Genomics had 1:20 split on the 12th of July 2005. DNAPrint Genomics, Inc. engages in the development and marketing of genetic testing products and services. The company was incorporated in 1983 and is based in Sarasota, Florida with a subsidiary in Leverkusen, Germany. DNAPRINT GENOMICS is traded on OTC Exchange in the United States. To learn more about DNAPrint Genomics call the company at 941-366-3400.

DNAPrint Genomics Investment Alerts

DNAPrint Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 386.76 K.

DNAPrint Profitablity

The company has Profit Margin (PM) of (2.36) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (7.31) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $7.31.

Management Efficiency

DNAPrint Genomics has return on total asset (ROA) of (1.05) % which means that it has lost $1.05 on every $100 spent on assets. This is way below average. DNAPrint Genomics' management efficiency ratios could be used to measure how well DNAPrint Genomics manages its routine affairs as well as how well it operates its assets and liabilities. The DNAPrint Genomics' current Return On Equity is estimated to increase to 4.02, while Return On Tangible Assets are projected to decrease to (1.16). At this time, DNAPrint Genomics' Other Current Assets are most likely to increase significantly in the upcoming years. The DNAPrint Genomics' current Total Current Assets is estimated to increase to about 10.6 M, while Return On Tangible Assets are projected to decrease to (1.16).

Technical Drivers

DNAPrint Genomics technical analysis allows you to utilize past data patterns in order to determine a pattern that computes the direction of the firm's future prices.

DNAPrint Genomics Price Movement Analysis

DNAPrint Genomics Outstanding Bonds

DNAPrint Genomics Bond Ratings

DNAPrint Genomics financial ratings play a critical role in determining how much DNAPrint Genomics have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for DNAPrint Genomics' borrowing costs.

DNAPrint Genomics Debt to Cash Allocation

DNAPrint Genomics currently holds 240 K in liabilities. DNAPrint Genomics has a current ratio of 0.17, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about DNAPrint Genomics' use of debt, we should always consider it together with its cash and equity.

DNAPrint Genomics Total Assets Over Time

DNAPrint Genomics Assets Financed by Debt

The debt-to-assets ratio shows the degree to which DNAPrint Genomics uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

DNAPrint Genomics Debt Ratio

76.0

It seems as most of the DNAPrint Genomics' assets are financed through debt. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the DNAPrint Genomics' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of DNAPrint Genomics, which in turn will lower the firm's financial flexibility.

DNAPrint Genomics Corporate Bonds Issued

DNAPrint Long Term Debt

Stock analysis is the technique used by a trader or investor to examine and evaluate how DNAPrint Genomics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling DNAPrint shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as DNAPrint Genomics. By using and applying DNAPrint Stock analysis, traders can create a robust methodology for identifying DNAPrint entry and exit points for their positions.

When running DNAPrint Genomics' price analysis, check to measure DNAPrint Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DNAPrint Genomics is operating at the current time. Most of DNAPrint Genomics' value examination focuses on studying past and present price action to predict the probability of DNAPrint Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DNAPrint Genomics' price. Additionally, you may evaluate how the addition of DNAPrint Genomics to your portfolios can decrease your overall portfolio volatility.